• News by Topic

  • News by Topic

  • Relationships news

  • Mind and body

    "Live as if your were to die tomorrow. Learn as if you were to live forever. You must learn to be still in the midst of activity and be vibrantly alive in repose."


This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.


FDA Approves New Sleep Medication

Last week, the Food and Drug Administration (FDA) approved Belsomra (suvoraxant) to treat individuals with insomnia. The drug, which antagonizes molecular pathways of orexins—chemicals involved in keeping people awake—is the first of its kind to receive such approval.Effectiveness of Belsomra was studied in three clinical trials totaling more than 500 participants who were given various doses (5mg, 10mg, 15mg, or 20 mg) of the orexin antagonist or a placebo. The results showed that the patients in the Belsomra group fell asleep faster and spent less time awake during the night when compared with individuals taking placebo. Furthermore,...


Share |

Published By: Psychiatric News - Friday, 22 August, 2014

Copyright © 2016 Psychology One. All rights reserved. This site is for education & information purposes. This site is not a substitute for professional psychological, medical or psychiatric treatment.